SYNAPS Dx Completes $10 Million Series A Investment, Accelerates Commercialization of DISCERN: First Minimally Invasive Test for Accurate Diagnosis of Alzheimer’s Disease ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease (AD), announces the close

COVID-19 Cases, Hospitalizations Drop as Poll Shows 20% of Adults Won’t Get Vaccinated By Cecelia Smith-Schoenwalder USNews.com—Nationwide coronavirus cases and hospitalization are down while a poll reports that the percentage of U.S. adults vaccinated or planning to get the shot is the highest it’s been this year. The U.S. is averaging over 110,000

Stakeholder panel calls for stronger price transparency enforcement, data accessibility By Dave Muoio FierceHealthcare.com—Many U.S. hospitals have not been publishing their prices, as required by a new law. Now, a panel of researchers, purchasers and regulators is calling for new measures around increasing compliance and the usability of published pricing data.   To

Recuro Health Announces Its $15 Million Series A Round Led by ARCH Venture Partners: Funds Additional Acquisitions Expanding Digital Health Solutions Capabilities, Increased Marketing, Company Growth DALLAS--(BUSINESS WIRE)--Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes